In comparison to healthy individuals, GBM patients exhibit significantly elevated levels of the enzymes 6-phosphogluconolactonase (PGLS) and 6-phosphogluconate dehydrogenase (PGD). The gene discussed is PGLS; the disease is glioblastoma.